Cite
HARVARD Citation
Luo, J. et al. (2014). Cobalt Protoporphyrin Pretreatment Protects Human Embryonic Stem Cell‐Derived Cardiomyocytes From Hypoxia/Reoxygenation Injury In Vitro and Increases Graft Size and Vascularization In Vivo. Stem cells translational medicine. pp. 734-744. [Online].